ClinicalTrials.gov record
Terminated Phase 3 Interventional

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT00090129

Public ClinicalTrials.gov record NCT00090129. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre, Randomised, Double-blind, Placebo Controlled Phase III Study of Subcutaneously Administered Onercept in the Treatment and Re-treatment of Subjects With Moderate to Severe Plaque Psoriasis

Study identification

NCT ID
NCT00090129
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
EMD Serono
Industry
Enrollment
854 participants

Conditions and interventions

Interventions

  • Onercept Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2004
Primary completion
May 31, 2005
Completion
May 31, 2005
Last update posted
Oct 21, 2013

2004 – 2005

United States locations

U.S. sites
37
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Bressnick Gibson Parker Dinehart Sangster Dermatology, P.A. Little Rock Arkansas 72205
Associates in Research Inc. Fresno California 93710
University of California, Irvine Irvine California 92697
Therapeutics Clinical Research La Jolla California 92037
University of California San Francisco California 94108
Clinical Research Specialists Inc. Santa Monica California 90404
Solano Clinical Research Vallejo California 94589
Dermatology Specialists Inc Vista California 92083
Colorado Medical Research Center Denver Colorado 80210
Cherry Creek Research, Inc. Denver Colorado 80246
Longmont Clinic PC Longmont Colorado 80501
The Savin Center P.C. New Haven Connecticut 06511
Dermatology Associates, P.C. at the Washington Hospital CTR Washington D.C. District of Columbia 20010
North Florida Dermatology Associates, P.A. Jacksonville Florida 32204
Jacksonville Center for Clinical Research Jacksonville Florida 32216
International Dermatology Research Miami Florida 33144
Atlanta Dermatology Vein & Research Center Alpharetta Georgia 30005
Scott D. Glazer, MD Buffalo Grove Illinois 60089
University of Michigan Department of Dermatology Ann Arbor Michigan 48109
Midwest Cutaneous Research Corporation Clinton Township Michigan 48038
Minnesota Clinical Study Center Fridley Minnesota 55432
Academic Dermatology Associates Albuquerque New Mexico 87106
Piedmont Medical Research Associates Winston-Salem North Carolina 27103
Wake Forest Univ School of Medicine Winston-Salem North Carolina 27157
Northwest Cutaneous Research Specialist Portland Oregon 97210
Oregon Medical Research Center, P.C. Portland Oregon 97223
Rivergate Dermatology Goodlettsville Tennessee 37072
Saint Mary's Centeral Wing Annex Knoxville Tennessee 37917
Tennessee Clinical Research Center Nashville Tennessee 37221
DermResearch Inc Austin Texas 78759
Texas Dermatology Research Institute Dallas Texas 75230
Center For Clinical Studies Houston Texas 77030
University Texas M.D. Anderson Cancer Center Houston Texas 77030
Center for Clinical Studies Houston Texas 77058
Virginia Clinical Research, Inc Norfolk Virginia 23507
Dermatology Associates P.L.L.C. Seattle Washington 98101
Rockwood Clinic, PS Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00090129, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2013 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00090129 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →